These findings prompted us to analyze whether dystroglycanopathy-associated mutations in human POMT1 also affect enzymatic activity of yeast Pmt4. Here, POMT1 is linked to neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.